- Home
- RLAY vs WABC Comparison
RLAY vs WABC Comparison
Compare RLAY & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | WABC |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | WABC |
|---|---|---|
| Price | $7.82 | $48.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 2 |
| Target Price | $16.00 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 2.3M | 125.1K |
| Earning Date | 11-06-2025 | 01-15-2026 |
| Dividend Yield | N/A | ★ 3.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.59 |
| Revenue | $8,355,000.00 | ★ $264,660,000.00 |
| Revenue This Year | $27.30 | N/A |
| Revenue Next Year | $7.43 | N/A |
| P/E Ratio | ★ N/A | $10.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.78 | $42.00 |
| 52 Week High | $8.36 | $58.24 |
Technical Indicators
Market Signals| Indicator | RLAY | WABC |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 51.51 |
| Support Level | $6.28 | $47.41 |
| Resistance Level | $8.36 | $50.04 |
| Average True Range (ATR) | 0.50 | 1.22 |
| MACD | 0.14 | 0.12 |
| Stochastic Oscillator | 76.56 | 44.62 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.